top border
top border
Featured Programs

Dr. Finn on Regorafenib for the Treatment of Patients With HCC
Richard Finn, assistant professor of Medicine at the Geffen School of Medicine, Department of Medicine, Division of Hematology/Oncology at UCLA Jonsson Comprehensive Cancer Center, discusses regorafenib (Stivarga) for the treatment of patients with hepatocelluar carcinoma (HCC). View Now

Led by Johanna Bendell, MD, panelists Thomas A. Abrams, MD; George P. Kim, MD; Caio Max Rocha Lima, MD; and Philip A. Philip, MD, PhD, focus on emerging evidence in pancreatic cancer and how it is likely to impact patient care. View Now

 

OncLive News Network

Post-Conference Perspectives in Gastrointestinal Cancers

Post-Conference Perspectives in GI Cancers
Ghassan K. Abou-Alfa, MD, and Diane Reidy Lagunes, MD, discuss key findings that came out of the 2017 Gastrointestinal Cancers Symposium in order to provide viewers with practical advice on the current and future application of new information into clinical care.
View Now

Gina Columbus

Gina Columbus reports on the latest news in oncology in this week's edition of OncLive News Network.

Publication Bottom Border
Border Publication